Work

Faculty Opinions recommendation of Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

Year: 2011

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.9144956.9727057

Authors: Michael Deininger, Paul La Rosée

Institutions: University of Utah, Huntsman Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4238067305

Cites:

Cited by:

Related to: 10